Xtant Medical Holdings, Inc. 8-K

What Happened Xtant Medical Holdings, Inc. (XTNT) announced it received $10.7 million from Companion Spine on February 27, 2026. The payment represented full repayment of an $8.2 million unsecured promissory note (plus accrued interest) and settlement of net working capital and other purchase price adjustments related to prior divestitures of Coflex and CoFix assets and the sale of Paradigm Spine GmbH. The initial sale closing occurred on December 1, 2025.

Key Details

• Original aggregate purchase price for the two divestitures was $19.2 million; after adjustments the total became $21.4 million.
• Companion Spine had issued an $8.2 million unsecured promissory note scheduled to mature January 31, 2026; XTNT received full repayment plus accrued interest.
• Of the $10.7 million received, $2.8 million was used to prepay part of XTNT’s term loan with MidCap Financial Trust, leaving $11.1 million of term loan principal outstanding as of this filing (dated March 2, 2026).
• The divested assets included Coflex and CoFix products and all outstanding stock of Paradigm Spine GmbH (XTNT’s hardware business outside the U.S.).

Why It Matters This cash receipt completes the payment arrangements from XTNT’s recent divestitures, increases realized proceeds to $21.4 million, and provided liquidity that was partly used to reduce outstanding term loan debt. For investors, these are concrete changes to XTNT’s cash flow and balance sheet: proceeds from the sales are now collected, and debt levels were modestly reduced, which can affect near-term financial flexibility and interest obligations.